CYP11B2 and glucocorticoid-remediable aldosteronism: The estimated prevalence of GRA is only 1% of PA subjects and is secondary to a chimeric gene with recombination of 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes [17,38].